Utility of Three-Dimensional Transesophageal Echocardiography for Mitral Annular Sizing in Transcatheter Mitral Valve Replacement Procedures: A Cardiac Computed Tomographic Comparative Study.


Journal

Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography
ISSN: 1097-6795
Titre abrégé: J Am Soc Echocardiogr
Pays: United States
ID NLM: 8801388

Informations de publication

Date de publication:
10 2020
Historique:
received: 07 11 2019
revised: 17 04 2020
accepted: 17 04 2020
pubmed: 29 7 2020
medline: 25 9 2021
entrez: 29 7 2020
Statut: ppublish

Résumé

Three-dimensional (3D) transesophageal echocardiographic (TEE) imaging is frequently used as an initial screening tool in the evaluation of patients who are candidates for transcatheter mitral valve replacement (TMVR). However, little is known about the imaging correlation with the gold standard, computed tomographic (CT) imaging. The aims of this study were to test the quantitative differences between these two modalities and to determine the best 3D TEE parameters for TMVR screening. Fifty-seven patients referred to the heart valve clinic for TMVR with prostheses specifically designed for the mitral valve were included. Mitral annular (MA) analyses were performed using commercially available software on 3D TEE and CT imaging. Three-dimensional TEE imaging was feasible in 52 patients (91%). Although 3D TEE measurements were slightly lower than those obtained on CT imaging, measurements of both projected MA area and perimeter showed excellent correlations, with small differences between the two modalities (r = 0.88 and r = 0.92, respectively, P < .0001). Correlations were significant but lower for MA diameters (r = 0.68-0.72, P < .0001) and mitroaortic angle (r = 0.53, P = .0001). Receiver operating characteristic curve analyses showed that 3D TEE imaging had a good ability to predict TMVR screening success, defined by constructors on the basis of CT measurements, with ranges of 12.9 to 15 cm Three-dimensional TEE measurements of MA dimensions display strong correlations with CT measurements in patients undergoing TMVR screening. Three-dimensional TEE imaging should be proposed as a reasonable alternative to CT imaging in this vulnerable population.

Sections du résumé

BACKGROUND
Three-dimensional (3D) transesophageal echocardiographic (TEE) imaging is frequently used as an initial screening tool in the evaluation of patients who are candidates for transcatheter mitral valve replacement (TMVR). However, little is known about the imaging correlation with the gold standard, computed tomographic (CT) imaging. The aims of this study were to test the quantitative differences between these two modalities and to determine the best 3D TEE parameters for TMVR screening.
METHODS
Fifty-seven patients referred to the heart valve clinic for TMVR with prostheses specifically designed for the mitral valve were included. Mitral annular (MA) analyses were performed using commercially available software on 3D TEE and CT imaging.
RESULTS
Three-dimensional TEE imaging was feasible in 52 patients (91%). Although 3D TEE measurements were slightly lower than those obtained on CT imaging, measurements of both projected MA area and perimeter showed excellent correlations, with small differences between the two modalities (r = 0.88 and r = 0.92, respectively, P < .0001). Correlations were significant but lower for MA diameters (r = 0.68-0.72, P < .0001) and mitroaortic angle (r = 0.53, P = .0001). Receiver operating characteristic curve analyses showed that 3D TEE imaging had a good ability to predict TMVR screening success, defined by constructors on the basis of CT measurements, with ranges of 12.9 to 15 cm
CONCLUSIONS
Three-dimensional TEE measurements of MA dimensions display strong correlations with CT measurements in patients undergoing TMVR screening. Three-dimensional TEE imaging should be proposed as a reasonable alternative to CT imaging in this vulnerable population.

Identifiants

pubmed: 32718722
pii: S0894-7317(20)30309-6
doi: 10.1016/j.echo.2020.04.030
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1245-1252.e2

Informations de copyright

Copyright © 2020 American Society of Echocardiography. Published by Elsevier Inc. All rights reserved.

Auteurs

Augustin Coisne (A)

Department of Clinical Physiology and Echocardiography - Heart Valve Center, CHU Lille, Lille, France; Université de Lille, U1011 - EGID, Lille, France; Inserm, U1011, Lille, France; Institut Pasteur de Lille, Lille, France. Electronic address: augustin.coisne@chru-lille.fr.

François Pontana (F)

Université de Lille, U1011 - EGID, Lille, France; Inserm, U1011, Lille, France; Institut Pasteur de Lille, Lille, France; Department of Cardiovascular Radiology, CHU Lille, Lille, France.

Samy Aghezzaf (S)

Department of Clinical Physiology and Echocardiography - Heart Valve Center, CHU Lille, Lille, France.

Stéphanie Mouton (S)

Department of Clinical Physiology and Echocardiography - Heart Valve Center, CHU Lille, Lille, France.

Hélène Ridon (H)

Department of Clinical Physiology and Echocardiography - Heart Valve Center, CHU Lille, Lille, France.

Marjorie Richardson (M)

Department of Clinical Physiology and Echocardiography - Heart Valve Center, CHU Lille, Lille, France.

Anne-Sophie Polge (AS)

Department of Clinical Physiology and Echocardiography - Heart Valve Center, CHU Lille, Lille, France.

Benjamin Longère (B)

Department of Cardiovascular Radiology, CHU Lille, Lille, France.

Valentina Silvestri (V)

Department of Cardiovascular Radiology, CHU Lille, Lille, France.

Julien Pagniez (J)

Department of Cardiovascular Radiology, CHU Lille, Lille, France.

Antoine Bical (A)

Department of Cardiovascular Surgery, CHU Lille, Lille, France.

Natacha Rousse (N)

Department of Cardiovascular Surgery, CHU Lille, Lille, France.

Pavel Overtchouk (P)

Department of Cardiovascular Surgery, CHU Lille, Lille, France.

Juan F Granada (JF)

Cardiovascular Research Foundation, Columbia University Medical Center, New York, New York.

Rebecca T Hahn (RT)

Columbia University Medical Center/NewYork-Presbyterian Hospital, New York, New York.

Thomas Modine (T)

Department of Cardiovascular Surgery, CHU Lille, Lille, France.

David Montaigne (D)

Department of Clinical Physiology and Echocardiography - Heart Valve Center, CHU Lille, Lille, France; Université de Lille, U1011 - EGID, Lille, France; Inserm, U1011, Lille, France; Institut Pasteur de Lille, Lille, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH